Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.

Patients with Crohn's disease (CD) or ulcerative colitis (UC) have high morbidity rates owing to debilitating intestinal complications and extraintestinal manifestations (EIMs). We retrospectively identified patients in the Truven MarketScan databases with an incident CD or UC diagnosis from January...

Descripción completa

Detalles Bibliográficos
Publicado en:Gastroenterology & Hepatology Vol. 18; no. 1; pp. 32 - 43
Autores principales: Lichtenstein, Gary R., Shahabi, Ahva, Seabury, Seth A., Lakdawalla, Darius N., Díaz Espinosa, Oliver, Green, Sarah, Brauer, Michelle, Baldassano, Robert N.
Formato: research tables/charts Journal Article
Publicado: Gastro-Hep Communications, Inc Jan2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=154696209&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 154696209
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15547914
        6N5B
      jtl: Gastroenterology & Hepatology
      issn: 15547914
      maglogo: N
    pubinfo:
      dt: Jan2022
      vid: 18
      iid: 1
      pid: 72163
      pub: Gastro-Hep Communications, Inc
      place: New York, New York
    artinfo:
      ui:
        154696209
        154696209
        154696209
        154696209
      ppf: 32
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.
      aug:
        au:
          Lichtenstein, Gary R.
          Shahabi, Ahva
          Seabury, Seth A.
          Lakdawalla, Darius N.
          Díaz Espinosa, Oliver
          Green, Sarah
          Brauer, Michelle
          Baldassano, Robert N.
        affil: Department of Medicine, Center for Inflammatory Bowel Disease, Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
      sug:
        subj:
          Crohn Disease Complications
          Colitis, Ulcerative Complications
          Intestinal Diseases Symptoms
          Intestinal Diseases Risk Factors
          Risk Assessment
          Human
          Matched Case Control
          Inflammatory Bowel Diseases Complications
          Crohn Disease Diagnosis
          Colitis, Ulcerative Diagnosis
          Retrospective Design
          Record Review
          Parametric Statistics
          Clinical Assessment Tools
          Age Factors
          Comorbidity
      ab: Patients with Crohn's disease (CD) or ulcerative colitis (UC) have high morbidity rates owing to debilitating intestinal complications and extraintestinal manifestations (EIMs). We retrospectively identified patients in the Truven MarketScan databases with an incident CD or UC diagnosis from January 2008 to September 2015 to quantify the incremental lifetime risk of experiencing an intestinal complication or EIM after CD or UC diagnosis. Seven intestinal complications and 13 categories of EIMs by site were identified, and lifetime risk of experiencing an intestinal complication or EIM from age at CD or UC diagnosis to end of life was estimated using parametric models. Results were compared with controls' propensity score matched by age, sex, health plan, and pre-index Charlson Comorbidity Index. The CD or UC incremental risk was calculated using the difference in rates between CD or UC patients and matched controls. A total of 34,692 CD patients and 48,196 UC patients with 1:1 matched controls were included. CD and UC patients had an increased lifetime risk of intestinal complications, which varied across ages, inflammatory bowel disease (IBD) types, and categories of intestinal complications and EIMs. CD and UC patients aged 0 to 11 years had the highest incremental lifetime risk for all 7 intestinal complications and the majority of EIMs, with blood EIMs associated with the highest incremental risk (CD: 32%; UC: 21%). CD and UC patients of all ages have a higher lifetime risk of experiencing intestinal complications and EIMs than patients without CD or UC. When evaluating the burden of disease on patients with IBD, it is important to include the burden of these intestinal complications and EIMs in the assessment.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N